Mednet Logo

When would you consider sequential chemotherapy and radiation rather than concurrent for early stage cervical cancer with high risk pathologic features?

The recently released STARS phase 3 RCT found improved DFS, decreased distant recurrence, with reduced toxicities for chemotherapy (cisplatin + taxol) followed by RT versus concurrent chemo-radiation.
2 Answers
Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

How much of the results of the STARS (Huang et al., PMID 33443541) (showing improved DFS with SCRT compared to CCRT) driven by only a 62% completion rate of CCRT (compared to 73.4% in SCRT, p< 0.001) as per the specified protocol is unknown.

While the authors state within their results section that t...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Kentucky
Answered on

A critical review of this paper is not appropriate in this forum. Yes, I would consider it. No, I don't believe that this paper creates a new standard of care at this point. The differences in OS are very small, and the overall compliance with the SCRT arm is still less than 75% (drop out rate mostl...

Join for free or sign in to see the full answer